R.a. Session II

Insider Reports History

Location
Bannockburn, IL
Signature
/s/ R.A. Session II
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R.a. Session II:

Company Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. 10%+ Owner Common Stock 8,871,747 $14,460,948 $1.63 13 Jul 2023 Direct
Taysha Gene Therapies, Inc. 10%+ Owner Common Stock 141,090 $229,977 $1.63 12 Jul 2023 Indirect

Insider Reports Filed by R.a. Session II

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TSHA Taysha Gene Therapies, Inc. 12 Jul 2023 2 -$60,771 4 10%+ Owner 14 Jul 2023, 16:00
TSHA Taysha Gene Therapies, Inc. 22 Jun 2023 2 -$20,119 4 10%+ Owner 26 Jun 2023, 16:46
TSHA Taysha Gene Therapies, Inc. 20 Jun 2023 2 -$307,844 4 10%+ Owner 22 Jun 2023, 16:00
TSHA Taysha Gene Therapies, Inc. 06 Mar 2023 2 $0 4 10%+ Owner 08 Mar 2023, 18:38
TSHA Taysha Gene Therapies, Inc. 10 Nov 2022 1 $0 4 Director, 10%+ Owner 23 Dec 2022, 15:15
TSHA Taysha Gene Therapies, Inc. 23 Feb 2022 1 $0 4 President and CEO, Director, 10%+ Owner 25 Feb 2022, 15:17
TSHA Taysha Gene Therapies, Inc. 23 Nov 2021 2 +$529,102 4 President and CEO, Director, 10%+ Owner 08 Dec 2021, 15:05